EP3515887 - TRPV4 ANTAGONISTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 13.05.2022 Database last updated on 31.08.2024 | |
Former | The patent has been granted Status updated on 12.06.2021 | ||
Former | Grant of patent is intended Status updated on 15.02.2021 | ||
Former | Examination is in progress Status updated on 04.03.2020 | ||
Former | Request for examination was made Status updated on 28.06.2019 | ||
Former | The international publication has been made Status updated on 30.03.2018 | ||
Former | unknown Status updated on 25.10.2017 | Most recent event Tooltip | 17.06.2022 | Lapse of the patent in a contracting state | published on 20.07.2022 [2022/29] | Applicant(s) | For all designated states GlaxoSmithKline Intellectual Property (No. 2) Limited 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [2019/31] | Inventor(s) | 01 /
BRNARDIC, Edward J. 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 02 /
BROOKS, Carl A. 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 03 /
LAWHORN, Brian Griffin 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 04 /
YE, Guosen 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 05 /
BARTON, Linda S. 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 06 /
BUDZIK, Brian W. 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 07 /
MATTHEWS, Jay M. 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 08 /
MCATEE, John Jeffrey 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 09 /
PATTERSON, Jaclyn R. 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 10 /
PERO, Joseph E. 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 11 /
SANCHEZ, Robert 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 12 /
SENDER, Matthew Robert 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 13 /
TERRELL, Lamont Roscoe 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 14 /
BEHM, David J. 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | 15 /
THOMAS, James V. 709 Swedeland Road King of Prussia, Pennsylvania 19406 / US | [2019/31] | Representative(s) | Knight, Lucie Viktoria, et al GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [2021/27] |
Former [2019/31] | Hillier, Mark GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 17784400.8 | 20.09.2017 | [2019/31] | WO2017IB55700 | Priority number, date | US201662396991P | 20.09.2016 Original published format: US 201662396991 P | US201762482296P | 06.04.2017 Original published format: US 201762482296 P | [2019/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018055524 | Date: | 29.03.2018 | Language: | EN | [2018/13] | Type: | A1 Application with search report | No.: | EP3515887 | Date: | 31.07.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.03.2018 takes the place of the publication of the European patent application. | [2019/31] | Type: | B1 Patent specification | No.: | EP3515887 | Date: | 07.07.2021 | Language: | EN | [2021/27] | Search report(s) | International search report - published on: | EP | 29.03.2018 | Classification | IPC: | C07D207/48, C07D401/12, C07D403/12, C07D413/12, C07D498/10, A61K31/40, A61K31/4439, A61K31/41, A61K31/506, A61P9/00, A61P1/16, A61P11/00, A61P11/14, A61P13/10 | [2019/31] | CPC: |
A61K31/40 (EP,KR,US);
C07D207/48 (EP,KR,US);
A61K31/4025 (EP,US);
A61K31/407 (EP,US);
A61K31/41 (KR);
A61K31/4155 (EP,US);
A61K31/424 (EP,US);
A61K31/4245 (EP,US);
A61K31/427 (EP,US);
A61K31/429 (EP,US);
A61K31/4439 (EP,KR,US);
A61K31/501 (EP,US);
A61K31/506 (EP,KR,US);
A61K31/5386 (EP,US);
A61K31/695 (EP,US);
A61K45/06 (US);
A61K9/0019 (US);
A61K9/0053 (US);
A61K9/0073 (US);
A61K9/2059 (US);
A61K9/4866 (US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/10 (EP);
A61P1/16 (EP,KR);
A61P1/18 (EP);
A61P11/00 (EP,KR);
A61P11/02 (EP);
A61P11/06 (EP);
A61P11/14 (EP,KR);
A61P13/10 (EP,KR);
A61P13/12 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P17/04 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/06 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P27/06 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
A61P31/04 (EP);
A61P37/04 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
A61P7/10 (EP);
A61P9/00 (EP,KR);
A61P9/04 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
C07D401/12 (EP,KR,US);
C07D403/12 (EP,KR,US);
C07D409/12 (EP,US);
C07D413/12 (EP,KR,US);
C07D417/12 (EP,US);
C07D491/107 (EP,US);
C07D498/10 (EP,KR,US);
C07D513/04 (EP,US);
C07F7/0812 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/31] | Extension states | BA | 25.03.2019 | ME | 25.03.2019 | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | TRPV4-ANTAGONISTEN | [2019/31] | English: | TRPV4 ANTAGONISTS | [2019/31] | French: | ANTAGONISTES DE TRPV4 | [2019/31] | Entry into regional phase | 25.03.2019 | National basic fee paid | 25.03.2019 | Designation fee(s) paid | 25.03.2019 | Examination fee paid | Examination procedure | 25.03.2019 | Examination requested [2019/31] | 25.03.2019 | Date on which the examining division has become responsible | 22.10.2019 | Amendment by applicant (claims and/or description) | 09.03.2020 | Despatch of a communication from the examining division (Time limit: M06) | 02.09.2020 | Reply to a communication from the examining division | 16.02.2021 | Communication of intention to grant the patent | 26.05.2021 | Fee for grant paid | 26.05.2021 | Fee for publishing/printing paid | 26.05.2021 | Receipt of the translation of the claim(s) | Opposition(s) | 08.04.2022 | No opposition filed within time limit [2022/24] | Fees paid | Renewal fee | 11.09.2019 | Renewal fee patent year 03 | 11.09.2020 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 07.07.2021 | [2022/29] | Cited in | International search | [A]WO2007082262 (SMITHKLINE BEECHAM CORP [US], et al) [A] 1-25 * claims 1,11 *; | [A]US2011021487 (HUEBSCH WALTER [DE], et al) [A] 1-25 * paragraph [0017]; examples 11a,28a; claim 1 *; | [AD] - SARAH E. SKERRATT ET AL, "Identification of false positives in "HTS hits to lead": The application of Bayesian models in HTS triage to rapidly deliver a series of selective TRPV4 antagonists", MEDCHEMCOMM, United Kingdom, (20130101), vol. 4, no. 1, doi:10.1039/C2MD20259J, ISSN 2040-2503, pages 244 - 251, XP055421415 [AD] 1-25 * figure 3; table 1 * DOI: http://dx.doi.org/10.1039/C2MD20259J | [A] - MASAMI KURIYAMA ET AL, "Copper(II)-Catalyzed Monoarylation of Vicinal Diols with Diaryliodonium Salts", CHEMISTRY - A EUROPEAN JOURNAL, (20120206), vol. 18, no. 6, doi:10.1002/chem.201102770, ISSN 0947-6539, pages 1591 - 1594, XP055421552 [A] 1-25 * table 3; compound 1g * DOI: http://dx.doi.org/10.1002/chem.201102770 | by applicant | GB2064336 | EP0069715 | GB2129691 | GB2169265 | GB2178965 | US4778054 | US4811731 | US5035237 | GB2242134 | US5590645 | US5860419 | US5873360 | US6032666 | US6321747 | US6378519 | US6536427 | WO03061743 | WO2007012871 | WO2007068896 | US8113199 | US8161968 | US8511304 | US8534281 | US8746242 | US9333310 | - GULER et al., J Neurosci, (20020000), vol. 22, pages 6408 - 6414 | - STROTMANN et al., Nat Cell Biol, (20000000), vol. 2, pages 695 - 702 | - VRIENS et al., Proc Natl Acad Sci U S A, (20040000), vol. 101, pages 396 - 401 | - WEGIERSKI et al., J Biol Chem., (20090000), vol. 284, pages 2923 - 33 | - FAN et al., J Biol Chem, (20090000), vol. 284, pages 27884 - 91 | - DELANY et al., Physiol. Genomics, (20010000), vol. 4, pages 165 - 174 | - THORNELOE et al., Sci Transl Med, (20120000), vol. 4, page 159ra148 | - JIAN et al., Am J Respir Cell Mol Biol, (20090000), vol. 38, pages 386 - 92 | - WILLETTE et al., J Pharmacol Exp Ther, (20080000), vol. 325, pages 466 - 74 | - ALVAREZ et al., Ciro Res, (20060000), vol. 99, pages 988 - 95 | - JIAN et al., Am J Respir Cell Mol Biol, (20080000), vol. 38, pages 386 - 92 | - ZHU et al., Hum Mol Genetics, (20090000), vol. 18, pages 2053 - 62 | - HAMANAKA et al., Am J Physiol, (20070000), vol. 293, pages 923 - 32 | - RAHAMAN et al., J Clin Invest, (20140000), vol. 124, pages 5225 - 38 | - BONVINI et al., J Allergy Clin Immunol, (20160000), vol. 138, pages 249 - 61 | - LIEDTKE; SIMON, Am J Physiol, (20040000), vol. 287, pages 269 - 71 | - BHARGAVE et al., Am J Rhinol, (20080000), vol. 22, pages 7 - 12 | - ALVAREZ et al., Circ Res., (20061027), vol. 99, no. 9, pages 988 - 95 | - BALAKRISHNA et al., Am J Physiol Lung Cell Mol Physiol, (20140000), vol. 307, pages L158 - 72 | - MORTY et al., Am J Physiol Lung Cell Mol Physiol, (20140000), vol. 307, pages L817 - 21 | - YIN et al., Am J Respir Cell Mol Biol, (20160000), vol. 54, pages 370 - 83 | - HAMANAKA et al., Am J Physiol Lung Cell Mol Physiol., (20071000), vol. ;293, no. 4, pages L923 - 32 | - TODAKA et al., J Biol Chem, (20040000), vol. 279, pages 35133 - 35138 | - GRANT et al., J Physiol, (20070000), vol. 578, pages 715 - 733 | - ALESSANDRI-HABER et al., J Neurosci, (20060000), vol. 26, pages 3864 - 3874 | - AUER-GRUMBACH et al., Nat Genet., (20090000), page 20037588 | - DENG et al., Nat Genet, (20090000), page 20037587 | - LANDOURE et al., Nat Genet., (20090000), page 20037586 | - EARLEY et al., Circ Res, (20050000), vol. 97, pages 1270 - 9 | - YANG et al., Am. J Physiol., (20060000), vol. 290, pages 1267 - L1276 | - MURAMATSU et al., J. Biol. Chem., (20070000), vol. 282, pages 32158 - 67 | - KRAKOW et al., Am J Hum Genet, (20090000), vol. 84, pages 307 - 15 | - ROCK et al., Nat Genet, vol. 40, pages 999 - 1003 | - MASUYAMA et al., Cell Metab, (20080000), vol. 8, pages 257 - 65 | - AKIYAMA et al., J Invest Dermatol, (20160000), vol. 136, pages 154 - 60 | - CHEN et al., J Biol Chem, (20160000), vol. 291, pages 10252 - 62 | - LI et al., Front Cell Neurosci, (20130000), vol. 7, page 17 | - JIE et al., Front Cell Neurosci, (20150000), vol. 9, page 141 | - VERGNOLLE, Biochem Pharmacol, (20140000), vol. 89, pages 157 - 61 | - MONAGHAN et al., PloS One, (20150000), vol. 10, page e0128359 | - JO et al., Proc Natl Acad Sci U S A, (20160000), vol. 113, pages 3885 - 90 | - YE et al., Cell, (20120000), vol. 151, pages 96 - 110 | - DUAN et al., Mol Genet Genomics, (20150000), vol. 290, pages 1357 - 65 | - THOMELONE et al., Sci Trans Med, (20120000), vol. 4, page 159ra148 | - BALAKRISHNA et al., Am J Physiol Lung Cell Mol Physiol., (20140000), vol. 307, pages L158 - L172 | - HILFIKER et al., ACS Med. Chem. Lett., (20130000), vol. 4, pages 293 - 296 | - SKERRATT et al., Med. Chem. Commun., (20130000), vol. 4, pages 244 - 251 | - EVERAERTS et al., Proc Natl Acad Sci U S A, (20100000), vol. 107, pages 19084 - 19089 | - VINCENT et al., Biochem Biophys Res Commun, (20090000), vol. 389, pages 490 - 494 | - BONVINI SJ et al., J Allergy Clin Immunol., (20160700), vol. 138, no. 1, pages 249 - 261 | - BASOGLU OK et al., Chest., (20150800), vol. 148, no. 2, pages 430 - 5 | - ABDULQAWI R et al., Lancet., (20150328), vol. 385, no. 9974, pages 1198 - 1205 | - MCALEXANDER MA et al., Pharmacol Exp Ther., (20140400), vol. 349, no. 1, pages 118 - 25 | - DELANY NS et al., Physiol Genomics, (20010119), vol. 4, no. 3, pages 165 - 74 | - Remington's Pharmaceutical Sciences, Mack Publishing Company | - The Handbook of Pharmaceutical Excipients, American Pharmaceutical Association and the Pharmaceutical Press | - ALCARAZ, L.; CRIDLAND, A.; KINCHIN, E., Org. Lett., (20010000), vol. 3, page 4051 |